ArticleMikrochimica acta2026
Establishment of a microinterface between zinc-porphyrin-organic framework and ZnO nanoparticles for electrochemiluminescence aptasensing microRNA-122 in living cancer cells.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A novel electrochemiluminescence aptasensor based on "ON-OFF-ON" signal switching strategy for chloramphenicol detection.Mikrochimica acta · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The precise detection of microRNAs (miRNAs) in tumor tissue is vital for the early diagnosis of cancer. In this work, we propose an electrochemiluminescence (ECL) aptasensing strategy for the sensitive detection of miRNA-122 in living cancer cells. To tremendously amplify the ECL response, a zinc-porphyrin-organic framework embraced with ZnO nanoparticles (NPs), which was synthesized through solvothermal synthesis using 5,10,15,20-tetra(4-pyridyl)porphyrin (TPyP) as linking ligand and zinc nitrate as precursor (represented by Zn-TPyP@ZnO), simultaneously served as bioplatform and ECL emitter in the presence of the coreactant K2S2O8. The generation of a microinterface between Zn-TPyP and ZnO NPs endowed fast electron transfer, improved catalytic performance, and superior biocompatibility. These advantages of the Zn-TPyP@ZnO heterojunction confers the system with strong reduction capability toward S2O82− to generate SO4•− and toward O2 to produce O2•− or •OH, as well as excellent anchoring capability for the miRNA-122-targeted aptamer. Therefore, the developed Zn-TPyP@ZnO-based ECL aptasensor demonstrated a wide linear detection range from 10 fM to 10 nM with an ultralow detection limit of 0.77 fM, accompanied with high selectivity, good stability, and excellent reproducibility. The constructed ECL aptasensor also showed promising application for the detection of miRNA-122 in living cancer cells. Thereby, the present work not only provides a new ECL aptasensing strategy for the sensitive detection of miRNA in living cancer cells but also puts forward the advancement of the early diagnosis of tumors.
Indexed as
Identifiers
41894050What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.